Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Taiyen Biotech CoTPE:1737 +0.47%82 PS Ratio is 1.95 as of Jul. 16, 2026, which is 4% below its 10-year median of 2.03. GuruFocus rates TPE:1737 with a GF Score™ of 82/100 and a GF Value™ of NT$32.07 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,940 Consumer Packaged Goods companies, Taiyen Biotech Co ranks worse than 75.77% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Taiyen Biotech Co's share price is NT$32.05.
Taiyen Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$16.41. Hence, Taiyen Biotech Co's PS Ratio for today is 1.95.
The historical rank and industry rank for Taiyen Biotech Co's PS Ratio or its related term are showing as below:
TPE:1737'
s PS Ratio Range Over the Past 10 Years
Min: 1.52 Med: 2.03 Max: 2.36
Current: 1.95
During the past 13 years, Taiyen Biotech Co's highest PS Ratio was 2.36. The lowest was 1.52. And the median was 2.03.
TPE:1737's PS Ratio is ranked worse than 75.77% of 1940
companies
in the Consumer Packaged Goods industry
Industry Median: 0.86
vs TPE:1737: 1.95
Taiyen Biotech Co Ltd revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Taiyen Biotech Co was 2.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -3.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -1.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 2.70% per year.
During the past 13 years, Taiyen Biotech Co's highest 3-Year average Revenue per Share Growth Rate was 18.60% per year. The lowest was -7.50% per year. And the median was 2.85% per year.
Back to Basics: PS Ratio
Taiyen Biotech Co (TPE:1737) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Taiyen Biotech Co PS Ratio Related Terms
Taiyen Biotech Co PS Ratio Historical Data
* Premium members only.
The historical data trend for Taiyen Biotech Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Taiyen Biotech Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiyen Biotech Co PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Taiyen Biotech Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Taiyen Biotech Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Taiyen Biotech Co's Share Price of today is NT$32.05. Taiyen Biotech Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$16.41.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Taiyen Biotech Co (TPE:1737) has a PS Ratio of 1.95 as of Jul. 16, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Taiyen Biotech Co and its competitors. This is near median its historical median of 2.03. Over the past decade, Taiyen Biotech Co's PS Ratio has ranged from 1.52 to 2.36. According to the industry distribution chart, Taiyen Biotech Co ranks #1470 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 75.8%.
Is Taiyen Biotech Co's PS Ratio too high?
Taiyen Biotech Co's current PS Ratio of 1.95 is near median its 10-year median of 2.03. Over the past 10 years, this metric has ranged from a low of 1.52 to a high of 2.36. The Consumer Packaged Goods industry median PS Ratio is 0.86. Taiyen Biotech Co's value of 1.95 is 126.7% above this industry median. Based on the distribution chart, Taiyen Biotech Co ranks #1470 out of 1940 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Taiyen Biotech Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's PS Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Taiyen Biotech Co ranks #1470 out of 1940 companies for PS Ratio. This places Taiyen Biotech Co in the lower half of its industry. The industry median PS Ratio is 0.86. Taiyen Biotech Co's value of 1.95 is 126.7% above this benchmark. Historically, Taiyen Biotech Co's own PS Ratio has ranged from 1.52 to 2.36 over the past decade. While the company's 10-year median is 2.03 vs. the industry median of 0.86, Taiyen Biotech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.86, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiyen Biotech Co's current PS Ratio of 1.95 is 126.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Taiyen Biotech Co and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiyen Biotech Co's current PS Ratio is 1.95, which is near median its own 10-year median of 2.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.07, compared to a current price of NT$32.05 — trading 0.1% below its estimated fair value. The current PS Ratio is 1.95, which is near median its 10-year median of 2.03 and 126.7% above the Consumer Packaged Goods industry median of 0.86. Taiyen Biotech Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current PS Ratio is 1.95 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?
Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued.
The current stock price of NT$32.05 is trading 0.1% below its estimated GF Value™ of NT$32.07.
GuruFocus considers Taiyen Biotech Co to be Fairly Valued.
Key valuation signals for TPE:1737:
PS Ratio: 1.95 (near median its 10-year median of 2.03)
GF Value™: NT$32.07 vs. price of NT$32.05 (0.1% below fair value)
Industry Position: 126.7% above the Consumer Packaged Goods median (#1470 of 1940)
No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
82GF Score
Get the complete analysis for TPE:1737
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1737 has been successfully added to your 
